Table 3.
Comparison of changes in physical parameters and remission rates of obesity-related comorbidities 2 years after LSG
| CO | PPO | p value | |
|---|---|---|---|
| ΔBody weight, kg | −38.2±1.7 | −35.0±1.4 | 0.143 |
| ΔBMI, kg/m2 | −13.9±0.6 | −12.9±0.5 | 0.180 |
| %TWL, % | 30.1±11.7 | 29.7±10.6 | 0.772 |
| ΔFPG, mg/dL | −15.0 (−37.0 to [–5.0]) | −20.0 (−45.0 to [–8.0]) | 0.234 |
| ΔHbAlc, % | −0.7 (−1.7 to [–0.4]) | −1.0 (−2.0 to [–0.5]) | 0.163 |
| ΔTC, mg/dL | −0.6±6.5 | −8.3±4.2 | 0.298 |
| ΔTG, mg/dL | −57.0 (−110.8 to 1.0) | −61.0 (−106.0 to [–15.0]) | 0.372 |
| ΔHDL-C, mg/dL | 17.5±2.2 | 14.7±1.3 | 0.241 |
| ΔSerum creatinine, mg/dL | 0.40 (−0.43 to 0.90) | −0.20 (−0.70 to 0.50) | 0.014* |
| ΔUric acid, mg/dL | −0.9±0.2 | −0.8±0.1 | 0.693 |
| ΔSBP, mmHg | −3.2±2.6 | 1.6±1.6 | 0.115 |
| ΔDBP, mmHg | 0.3±1.9 | 0.8±1.2 | 0.819 |
| ΔVFA, cm2 | −84.7 (−123.9 to [–37.2]) | −132.7 (−186.8 to [–82.7]) | 0.063 |
| ΔSFA, cm2 | −145.1 (−254.9 to [–92.9]) | −108.7 (−274.5 to [–78.9]) | 0.520 |
| ΔVFA/SFA ratio | −0.07 (−0.17 to [–0.16]) | −0.10 (−0.24 to [–0.28]) | 0.324 |
| CR of diabetes, % | 80.0 | 65.6 | 0.061 |
| Complete or partial remission of diabetes, % | 83.6 | 77.1 | 0.337 |
| Remission of dyslipidemia, % | 57.7 | 65.6 | 0.196 |
| Remission of hypertension, % | 47.4 | 32.1 | 0.028* |
| Remission of OSAS, % | 58.4 | 66.2 | 0.236 |
Data are presented as mean±SD or median (interquartile range) or percentage. CO, childhood onset obesity; PPO, post-puberty onset obesity; BMI, body mass index; %TWL, percent total weight loss; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; VFA, visceral fat area; SFA, subcutaneous fat area; OSAS, obstructive sleep apnea syndrome; LSG, laparoscopic sleeve gastrectomy; SD, standard deviation; CR, complete remission.
*
p value ≤0.05.